SlideShare une entreprise Scribd logo
1  sur  39
Metabolism
Dr. Urmila M. Aswar
Definition
• The metabolism of drugs and other
xenobiotics into more hydrophilic
metabolites is essential for the
elimination of these compounds from
the body and termination of their
biological activity.
• INACTIVATION-Generates more polar (water soluble),
inactive metabolites eg Pentobarbitone
• Readily excreted from body
• ACTIVATION-Metabolites may still have potent
biological activity (or may have toxic properties) eg
Phenylbutazone: oxyphenylbutazone
• ACTIVATION OF INACTIVATED DRUG- Prodrug concept
eg Levodopa: dopamine
• Generally applicable to metabolism of all xenobiotics
as well as endogenous compounds such as steroids,
vitamins and fatty acids
Site of Biotransformation
• Enzymatic in nature
• Enzyme systems involved are localized in liver
• Every tissue has some metabolic activity
• Other organs with significant metabolic
capacity are GIT, kidneys and lung
• The main biotransformation reactions are
• Nonsynthetic/ Phase I
• Synthetic/ conjugated/ Phase II
First-Pass Metabolism
• Following nonparenteral administration of
a drug, a significant portion of the dose
may be metabolically inactivated in either
the intestinal endothelium or the liver
before it reaches the systemic circulation
• Limits oral availability of highly metabolized
drugs
Phase I and Phase II Metabolism
• Phase I
–functionalization reactions
• Phase II
–conjugation reactions
Phase I Metabolism
Includes oxidation, reduction, hydrolysis, and
hydration and isomerization
Eg barbiturates, phenothiazines, paracetamol,
steroids, benzodiazepines
• Many drugs undergo a number of these reactions
• Main function of Phase I metabolism is to prepare the
compound for phase II metabolism
• Mixed function enzyme system found in microsomes
of many cells (liver, kidney, lung, intestine) performs
many different functionalization reactions
Phase I
• Converts the parent drug to a more polar
metabolite by introducing or unmasking a
functional group (-OH, -NH2, -SH).
• Usually results in loss of pharmacological activity
• Sometimes may be equally or more active than
parent (Prodrug)
Prodrug
• Pharmacologically inactive
• Converted rapidly to active metabolite
(usually hydrolysis of ester or amide bond)
• Maximizes the amount of active species
that reaches site of action
• Eg Enalpril to enalprilat
• Levodopa to dopamine
Endoplasmic Reticulum
(microsomal) and Cytosol
With respect to drug metabolizing reactions,
two sub cellular organelles are quantitatively
the most important: the endoplasmic
reticulum and the cytosol.
The Phase I oxidative enzymes are almost
exclusively localized in the endoplasmic
reticulum (Microsomal). Egs P450, Glucuronyl
transferase
Phase II enzymes are located predominantly in
the cytosol. Egs esterases, amidases,
conjugases
Cytochrome P450 Monooxygenase
System
• Superfamily of heme containing proteins
Involved in metabolism of diverse
endogenous and exogenous compounds
– Drugs
– Environmental chemicals
– Other xenobiotics
Cytochrome P450 Nomenclature and
Multiple Forms
• About 1000 are currently known cytochrome
P450s, about 50 active in humans
• Basis of nomenclature system: P is
pigment, 450 absorption at 450 nm
• categorized into 17 families (CYPs)
– sequences > 40% identical
– identified by Arabic number, CYP1, CYP2
• further into subfamilies
– identified by a letter, CYP1A, CYP2D
These are the types of reactions performed by
the Cytochrome P450 system
• Aromatic hydroxylation Phenobarbital, amphetamine
• N-Dealkylation Diazepam
• Aliphatic hydroxylation Ibuprofen, cyclosporine
• Epoxidation Benzo [a] pyrene
• O- Dealkylation Codeine
• S- Dealkylation 6-Methylthiopurine
• Oxidative Deamination Diazepam, amphetamine
• N-Oxidation Chlorpheniramine
• S-Oxidation Chlorpromazine, cimetidine
• Phosphothionate oxidation Parathion
• Dehalogenation Halothane
• Alcohol oxidation Ethanol
Phase I Metabolism Summary
• The final product usually contains a chemical
reactive functional group OH, NH2, SH, COOH.
• This functional group can be acted upon by the
phase II or conjugative enzymes.
• Main function of Phase I metabolism is to
prepare the compound for phase II
metabolism, not excretion.
Phase II (conjugation reactions)
• Subsequent reaction in which a covalent linkage is
formed between a functional group on the parent
compound or Phase I metabolite and an
endogenous substrate such as glucuronic acid,
sulfate, acetate, or an amino acid
• Highly polar – rapidly excreted in urine and feces
• Usually inactive – (exception is morphine 6-
glucuronide)
• Eg sulphonamides, adrenaline, chloramphenicol
Phase II Metabolism
• Phase II is usually the true detoxification of
drugs
• Occurs mostly in cytosol
• Gives products that are generally water
soluble and easily excreted
• Includes sugar conjugation, sulfation,
methylation, acetylation, amino acid
conjugation, glutathione conjugation
Glucuronidation
• Most widespread, important of the
conjugation reactions.
• compounds with hydroxyl or carboxylic
acid group are conjugated with glucuronic
acid.
• Other sugars, glucose, xylose or ribose may
be conjugated
• Egs oral contaceptives
Sulfation
• Major conjugation pathway for phenols, also
alcohols and amines
• Compounds that can be glucuronidated can
also be sulfated
• Can be competition between the two
pathways
• Sulfate conjugation - low substrate
concentration
• Glucuronide conjugation - high substrate
concentration
• Compds are sulfated by sulfokinases eg
Chloramphenicol.
Glutathione Conjugation
• Glutathione is a protective compound
within the body for removal of potentially
toxic electrophilic compounds
• Many drugs are, or are metabolized in
phase I to, strong electrophiles eg quinone
residues
• React with glutathione to form non- toxic
conjugates
• Glutathione conjugates may be excreted
directly in urine or bile.
Factors affecting Drug Metabolism
• Environmental Determinants
Induction
Inhibition
• Disease Factors
• Age and Sex
• Genetic Variation
Environmental Determinants
• Activity of most drug metabolizing enzymes can be
modulated by exposure to certain exogenous
compounds
Drugs
Dietary micronutrient (food additives,
nutritional or preservative)
Environmental factors (pesticides, industrial
chemicals)
• Can be in the form of induction or inhibition
• Contributes to interindividual variability in the
metabolism of many drugs
Induction of Drug Metabolism
Enzyme induction is the process:
Certain substrates (e.g., drugs, environmental
pollutants) causes increased activity/ synthesis
of certain enzymes resulting in increased
metabolism of administered drug.
Induction of Drug Metabolism
• Many currently used drugs are well known to
induce their own metabolism or the metabolism
of other drugs. Some examples are the
anticonvulsant medications phenobarbital and
carbamazepine.
• Cigarette smoking can cause increased
elimination of theophylline and other
compounds.
Consequences of Induction
1. Increased rate of metabolism
2. Decrease in drug plasma concentration
3. Enhanced oral first pass metabolism
4. Reduced bioavailability
5. If metabolite is active or reactive,
increased drug effects or toxicity
Therapeutic Implications of Induction
• Drugs with active metabolites can display
increased drug effect and/or toxicity due to
enzyme induction
• Dosing rates may need to be increased to
maintain effective plasma concentrations
Inhibition of Drug Metabolism
• Drug metabolism can be subjected to
inhibition.
• Drugs and other substances can inhibit the
metabolism of other drugs.
Some types of inhibition
• Competition between substrates for enzyme active site
• Concentration of substrates
Affinity for binding site (drug with high affinity for an
enzyme will slow the metabolism of any low affinity
drug)
• Irreversible inactivation of enzyme: Eg Complex with
heme iron of CYP450 (cimetidine, ketoconazole),
Destruction of heme group (secobarbital)
Consequences of Inhibition
• Increase in the plasma concentration of
parent drug
• Reduction in metabolite concentration
• Exaggerated and prolonged
pharmacological effects
• Increased liklihood of drug-induced
toxicity
Therapeutic Implications of Inhibition
• May occur rapidly with no warning
• Particularly effects drug prescribing for
patients on multidrug regimens
• Knowledge of the CYP450 metabolic pathway
provides basis for predicting and
understanding inhibition
Esp drug drug interaction
Examples of enzyme inducers and
inhibitors in metabolism
Affected Drugs Inducers Inhibitors
Tricyclicantidepressants
Propranolol
F-Warfarin
Theophylline
Phenobarbital
Phenytoin
Rifampin
Smoking
Char-broiled meats
Cimetidine
Erythromycin
Ciprofloxacin
sulfonamides
Disease Factors
Liver Disease – Cirrhosis, Alcoholic liver disease,
jaundice, carcinoma
• Major location of drug metabolizing enzymes
• Dysfunction can lead to impaired drug metabolism-decreased
enzyme activity
• First pass metabolism affected
• Results in exaggerated pharmacological responses and adverse
effects
Cardiac failure causes decreased blood flow to the liver
Hormonal diseases, infections and inflammation can
change drug metabolizing capacity
Age
• Newborns and infants – metabolize drugs
relatively efficiently but at a rate generally
slower than adults
• Full maturity appears in second decade of
life
• Slow decline in function associated with
aging
• Sex: Responsiveness to certain drugs is
different for men and women
• Pregnancy – induction of certain drug
metabolizing enzymes occurs in second and third
trimester
• Hormonal changes during development have
a profound effect on drug metabolism
• Genetic predisposition: Lactose intolerance-
deficiency of lactase- results in abdominal
bloating and cramps, flatulence, diarrhea, nausea
Excretion
• Urine: salicylates, probenicid
• Faeces: unabsorbed fraction, from bile eg steroids and
organic bases
• Egs erythromycin, rifamipin, tetracyclin,
phenolphthalein.
• Exhaled air: gases and voletile liquids egs alcohol,
paraldehyde, general anesthetics.
• Saliva and sweat: Lithium, Pot. Iodide, thiocynates,
rifampin and heavy metals
• Milk: drug enters milk by passive diffusion. Milk pH is 7
thus basic drug get more into it. Drug should be given
cautiously to the lactating mother.
• Glomerular filteration: depending on their
molecular size.
• Tubular absorption: lipid solubility and
ionization at urinary pH
• Thus pH of urine affects the excretion of drug
• Poisoning: barbiturate (acidic) and salicylate,
urine is alkalinized.
• Acidified incase of morphine and
amphetamine poisoning.
• Tubular secretion

Contenu connexe

Tendances

BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSMTuba Khan
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationhttp://neigrihms.gov.in/
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugsRajat Mahamana
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugsSuvarta Maru
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.pptramchoure90
 
Excretion renal and non-renal
Excretion renal and non-renalExcretion renal and non-renal
Excretion renal and non-renalNagaraju Ravouru
 
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Mr.S.SEETARAM SWAMY
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSagar Savale
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugsNaresh Gorantla
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicologySnehalChakorkar
 
Biotransformation of drug
Biotransformation of drugBiotransformation of drug
Biotransformation of drugSatigayatri
 
Elimination kinetics
Elimination kineticsElimination kinetics
Elimination kineticsLily Dubey
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drugNilesh Kulkarni
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugswonderingsoul114
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drugDr. SHUBHRAJIT MANTRY
 
Appetite stimulants and suppressants-Anorexiants,Pharmacology
Appetite stimulants and suppressants-Anorexiants,PharmacologyAppetite stimulants and suppressants-Anorexiants,Pharmacology
Appetite stimulants and suppressants-Anorexiants,PharmacologyNishanth Arunodayam
 
Pharmacology bioavailability
Pharmacology   bioavailabilityPharmacology   bioavailability
Pharmacology bioavailabilityMBBS IMS MSU
 

Tendances (20)

Factors modifying drug action
Factors modifying drug actionFactors modifying drug action
Factors modifying drug action
 
BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSM
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of elimination
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugs
 
Factors affecting absorption of drugs
Factors affecting absorption of drugsFactors affecting absorption of drugs
Factors affecting absorption of drugs
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Excretion renal and non-renal
Excretion renal and non-renalExcretion renal and non-renal
Excretion renal and non-renal
 
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
Sulphonamides (Sulfonamides) and Sulfones || B.Pharm VI Semester || Medicinal...
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
 
Biotransformation of drug
Biotransformation of drugBiotransformation of drug
Biotransformation of drug
 
Elimination kinetics
Elimination kineticsElimination kinetics
Elimination kinetics
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drug
 
Drug excretion
Drug excretionDrug excretion
Drug excretion
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drug
 
Appetite stimulants and suppressants-Anorexiants,Pharmacology
Appetite stimulants and suppressants-Anorexiants,PharmacologyAppetite stimulants and suppressants-Anorexiants,Pharmacology
Appetite stimulants and suppressants-Anorexiants,Pharmacology
 
Pharmacology bioavailability
Pharmacology   bioavailabilityPharmacology   bioavailability
Pharmacology bioavailability
 

En vedette

Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismsuniu
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismraj kumar
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismRIPS-14
 
Biotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsBiotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsZaigham Hammad
 
Drug metabolism : Biotransformation
Drug metabolism : BiotransformationDrug metabolism : Biotransformation
Drug metabolism : BiotransformationRahul Kunkulol
 
3. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_20113. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_2011drugmetabol
 
Drug metabolism /certified fixed orthodontic courses by Indian dental academy
Drug metabolism   /certified fixed orthodontic courses by Indian dental academy Drug metabolism   /certified fixed orthodontic courses by Indian dental academy
Drug metabolism /certified fixed orthodontic courses by Indian dental academy Indian dental academy
 
Metabolism of xenobiotics biochemistry BMN
Metabolism of xenobiotics biochemistry BMNMetabolism of xenobiotics biochemistry BMN
Metabolism of xenobiotics biochemistry BMNRupali Sengupta
 
Clinical pharmacokintics part 2 dr jayesh vaghela
Clinical pharmacokintics part 2 dr jayesh vaghelaClinical pharmacokintics part 2 dr jayesh vaghela
Clinical pharmacokintics part 2 dr jayesh vaghelajpv2212
 
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic MetabolismEUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic MetabolismChemAxon
 
INTRODUCTION TO BIOTRANSFORMATION OF DRUG (METABOLISM OF PHENYTOIN AND CODEINE)
INTRODUCTION TO BIOTRANSFORMATION OF DRUG  (METABOLISM OF PHENYTOIN AND CODEINE)INTRODUCTION TO BIOTRANSFORMATION OF DRUG  (METABOLISM OF PHENYTOIN AND CODEINE)
INTRODUCTION TO BIOTRANSFORMATION OF DRUG (METABOLISM OF PHENYTOIN AND CODEINE)ADAM S
 

En vedette (20)

Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Biotransformation
Biotransformation Biotransformation
Biotransformation
 
Xenobiotic Metabolism
Xenobiotic MetabolismXenobiotic Metabolism
Xenobiotic Metabolism
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Biotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsBiotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugs
 
Biotransformation
BiotransformationBiotransformation
Biotransformation
 
Xenobiotics
XenobioticsXenobiotics
Xenobiotics
 
Drug metabolism : Biotransformation
Drug metabolism : BiotransformationDrug metabolism : Biotransformation
Drug metabolism : Biotransformation
 
3. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_20113. 정병화식약청 사업단_심포지움_2011
3. 정병화식약청 사업단_심포지움_2011
 
The Food metabolome
The Food metabolomeThe Food metabolome
The Food metabolome
 
Dynamic Evolution and The Gut
Dynamic Evolution and The GutDynamic Evolution and The Gut
Dynamic Evolution and The Gut
 
Cytochrome P450
Cytochrome P450Cytochrome P450
Cytochrome P450
 
Drug metabolism /certified fixed orthodontic courses by Indian dental academy
Drug metabolism   /certified fixed orthodontic courses by Indian dental academy Drug metabolism   /certified fixed orthodontic courses by Indian dental academy
Drug metabolism /certified fixed orthodontic courses by Indian dental academy
 
Xenobiotics
XenobioticsXenobiotics
Xenobiotics
 
Metabolism of xenobiotics biochemistry BMN
Metabolism of xenobiotics biochemistry BMNMetabolism of xenobiotics biochemistry BMN
Metabolism of xenobiotics biochemistry BMN
 
Clinical pharmacokintics part 2 dr jayesh vaghela
Clinical pharmacokintics part 2 dr jayesh vaghelaClinical pharmacokintics part 2 dr jayesh vaghela
Clinical pharmacokintics part 2 dr jayesh vaghela
 
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic MetabolismEUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
 
INTRODUCTION TO BIOTRANSFORMATION OF DRUG (METABOLISM OF PHENYTOIN AND CODEINE)
INTRODUCTION TO BIOTRANSFORMATION OF DRUG  (METABOLISM OF PHENYTOIN AND CODEINE)INTRODUCTION TO BIOTRANSFORMATION OF DRUG  (METABOLISM OF PHENYTOIN AND CODEINE)
INTRODUCTION TO BIOTRANSFORMATION OF DRUG (METABOLISM OF PHENYTOIN AND CODEINE)
 
Xenobiotic
XenobioticXenobiotic
Xenobiotic
 

Similaire à Metabolism and excretion

Pharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionPharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionsumitmahato20
 
Drug Metabolism 2023 2nd year mbbs medical students.pptx
Drug Metabolism 2023 2nd year mbbs medical students.pptxDrug Metabolism 2023 2nd year mbbs medical students.pptx
Drug Metabolism 2023 2nd year mbbs medical students.pptxAsmatUllahQureshi
 
Biotransfermation of drugs by harsha
Biotransfermation of drugs by harshaBiotransfermation of drugs by harsha
Biotransfermation of drugs by harshaSriharsha Rayam
 
Biotransformation and elimination
Biotransformation and eliminationBiotransformation and elimination
Biotransformation and eliminationMaheshwari Hireholi
 
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...manjusha kareppa
 
Role of metabolism in drug discovery
Role of metabolism in drug discovery Role of metabolism in drug discovery
Role of metabolism in drug discovery ImranaToor
 
Metabolism/pharmacokinetics/pharmacy student notes
Metabolism/pharmacokinetics/pharmacy student notesMetabolism/pharmacokinetics/pharmacy student notes
Metabolism/pharmacokinetics/pharmacy student notesCyrelleAnnePerez
 
Hepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHossam Ghoneim
 
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTER
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTERUNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTER
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTERSONALI PAWAR
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptxbilaliqbal02
 
Metabolism of drugs
Metabolism of drugsMetabolism of drugs
Metabolism of drugsSOBIYAA3
 
Metabolism & Biotransformation
Metabolism & BiotransformationMetabolism & Biotransformation
Metabolism & BiotransformationChintanPatel322
 
biotransformation
 biotransformation  biotransformation
biotransformation zeelmevada
 
Xenobiotics and cyt p450 by dr rajender
Xenobiotics and cyt p450 by dr rajenderXenobiotics and cyt p450 by dr rajender
Xenobiotics and cyt p450 by dr rajenderrajender kumar arya
 
Metabolism of drugs Pharmacokinetics
Metabolism of drugs PharmacokineticsMetabolism of drugs Pharmacokinetics
Metabolism of drugs PharmacokineticsJaineel Dharod
 

Similaire à Metabolism and excretion (20)

METABOLISM
METABOLISMMETABOLISM
METABOLISM
 
Pharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionPharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretion
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Drug Metabolism 2023 2nd year mbbs medical students.pptx
Drug Metabolism 2023 2nd year mbbs medical students.pptxDrug Metabolism 2023 2nd year mbbs medical students.pptx
Drug Metabolism 2023 2nd year mbbs medical students.pptx
 
biopharma5.pptx
biopharma5.pptxbiopharma5.pptx
biopharma5.pptx
 
Biotransfermation of drugs by harsha
Biotransfermation of drugs by harshaBiotransfermation of drugs by harsha
Biotransfermation of drugs by harsha
 
Biotransformation and elimination
Biotransformation and eliminationBiotransformation and elimination
Biotransformation and elimination
 
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...
Medicinal chemistry -l-Second year-Fourth semester --Medichem drug metabolism...
 
Role of metabolism in drug discovery
Role of metabolism in drug discovery Role of metabolism in drug discovery
Role of metabolism in drug discovery
 
Metabolism/pharmacokinetics/pharmacy student notes
Metabolism/pharmacokinetics/pharmacy student notesMetabolism/pharmacokinetics/pharmacy student notes
Metabolism/pharmacokinetics/pharmacy student notes
 
Pharmacokinetics-2
Pharmacokinetics-2Pharmacokinetics-2
Pharmacokinetics-2
 
Hepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHepatic effects of dermatological drugs
Hepatic effects of dermatological drugs
 
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTER
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTERUNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTER
UNIT I: DRUG METABOLISM: S.Y. B. PHARMACY IV SEMESTER
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx
 
Metabolism of drugs
Metabolism of drugsMetabolism of drugs
Metabolism of drugs
 
Metabolism & Biotransformation
Metabolism & BiotransformationMetabolism & Biotransformation
Metabolism & Biotransformation
 
Pharmacology part 3
Pharmacology part 3Pharmacology part 3
Pharmacology part 3
 
biotransformation
 biotransformation  biotransformation
biotransformation
 
Xenobiotics and cyt p450 by dr rajender
Xenobiotics and cyt p450 by dr rajenderXenobiotics and cyt p450 by dr rajender
Xenobiotics and cyt p450 by dr rajender
 
Metabolism of drugs Pharmacokinetics
Metabolism of drugs PharmacokineticsMetabolism of drugs Pharmacokinetics
Metabolism of drugs Pharmacokinetics
 

Plus de Urmila Aswar

Hypolipidemic drugs.ppt
Hypolipidemic drugs.pptHypolipidemic drugs.ppt
Hypolipidemic drugs.pptUrmila Aswar
 
Hypertension and treatment.pptx
Hypertension and treatment.pptxHypertension and treatment.pptx
Hypertension and treatment.pptxUrmila Aswar
 
Case studies patent
Case studies patentCase studies patent
Case studies patentUrmila Aswar
 
Intellectual property appellate board
Intellectual property appellate boardIntellectual property appellate board
Intellectual property appellate boardUrmila Aswar
 
Parkinson's disease and alzheimer's disease
Parkinson's disease and alzheimer's diseaseParkinson's disease and alzheimer's disease
Parkinson's disease and alzheimer's diseaseUrmila Aswar
 
Pathophysiology of Coronary artery d isease
Pathophysiology of Coronary artery d iseasePathophysiology of Coronary artery d isease
Pathophysiology of Coronary artery d iseaseUrmila Aswar
 
Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Urmila Aswar
 
Pathophysiology of Leprosy
Pathophysiology of LeprosyPathophysiology of Leprosy
Pathophysiology of LeprosyUrmila Aswar
 
Cinical trial protocol writing
Cinical trial protocol writingCinical trial protocol writing
Cinical trial protocol writingUrmila Aswar
 
Randomisation techniques
Randomisation techniquesRandomisation techniques
Randomisation techniquesUrmila Aswar
 
Lipid metabolism and hypolipedemic drugs
Lipid metabolism and hypolipedemic drugsLipid metabolism and hypolipedemic drugs
Lipid metabolism and hypolipedemic drugsUrmila Aswar
 

Plus de Urmila Aswar (20)

Peptic ulcer.pptx
Peptic ulcer.pptxPeptic ulcer.pptx
Peptic ulcer.pptx
 
Hypolipidemic drugs.ppt
Hypolipidemic drugs.pptHypolipidemic drugs.ppt
Hypolipidemic drugs.ppt
 
Hypertension and treatment.pptx
Hypertension and treatment.pptxHypertension and treatment.pptx
Hypertension and treatment.pptx
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
Case studies patent
Case studies patentCase studies patent
Case studies patent
 
Intellectual property appellate board
Intellectual property appellate boardIntellectual property appellate board
Intellectual property appellate board
 
Patent search
Patent searchPatent search
Patent search
 
Malaria
MalariaMalaria
Malaria
 
Hypertension
HypertensionHypertension
Hypertension
 
Parkinson's disease and alzheimer's disease
Parkinson's disease and alzheimer's diseaseParkinson's disease and alzheimer's disease
Parkinson's disease and alzheimer's disease
 
Depression
DepressionDepression
Depression
 
Pathophysiology of Coronary artery d isease
Pathophysiology of Coronary artery d iseasePathophysiology of Coronary artery d isease
Pathophysiology of Coronary artery d isease
 
Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia
 
Pathophysiology of Leprosy
Pathophysiology of LeprosyPathophysiology of Leprosy
Pathophysiology of Leprosy
 
Arrythmias
ArrythmiasArrythmias
Arrythmias
 
Cinical trial protocol writing
Cinical trial protocol writingCinical trial protocol writing
Cinical trial protocol writing
 
Randomisation techniques
Randomisation techniquesRandomisation techniques
Randomisation techniques
 
Lipid metabolism and hypolipedemic drugs
Lipid metabolism and hypolipedemic drugsLipid metabolism and hypolipedemic drugs
Lipid metabolism and hypolipedemic drugs
 
Haematinics
HaematinicsHaematinics
Haematinics
 

Dernier

Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024The Digital Insurer
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Servicegiselly40
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationMichael W. Hawkins
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxFactors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxKatpro Technologies
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...Neo4j
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Igalia
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEarley Information Science
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 
The Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptxThe Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptxMalak Abu Hammad
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024The Digital Insurer
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slidevu2urc
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationRadu Cotescu
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Enterprise Knowledge
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking MenDelhi Call girls
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)Gabriella Davis
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationSafe Software
 

Dernier (20)

Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxFactors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
The Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptxThe Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptx
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 

Metabolism and excretion

  • 2. Definition • The metabolism of drugs and other xenobiotics into more hydrophilic metabolites is essential for the elimination of these compounds from the body and termination of their biological activity.
  • 3. • INACTIVATION-Generates more polar (water soluble), inactive metabolites eg Pentobarbitone • Readily excreted from body • ACTIVATION-Metabolites may still have potent biological activity (or may have toxic properties) eg Phenylbutazone: oxyphenylbutazone • ACTIVATION OF INACTIVATED DRUG- Prodrug concept eg Levodopa: dopamine • Generally applicable to metabolism of all xenobiotics as well as endogenous compounds such as steroids, vitamins and fatty acids
  • 4. Site of Biotransformation • Enzymatic in nature • Enzyme systems involved are localized in liver • Every tissue has some metabolic activity • Other organs with significant metabolic capacity are GIT, kidneys and lung • The main biotransformation reactions are • Nonsynthetic/ Phase I • Synthetic/ conjugated/ Phase II
  • 5. First-Pass Metabolism • Following nonparenteral administration of a drug, a significant portion of the dose may be metabolically inactivated in either the intestinal endothelium or the liver before it reaches the systemic circulation • Limits oral availability of highly metabolized drugs
  • 6. Phase I and Phase II Metabolism • Phase I –functionalization reactions • Phase II –conjugation reactions
  • 7. Phase I Metabolism Includes oxidation, reduction, hydrolysis, and hydration and isomerization Eg barbiturates, phenothiazines, paracetamol, steroids, benzodiazepines • Many drugs undergo a number of these reactions • Main function of Phase I metabolism is to prepare the compound for phase II metabolism • Mixed function enzyme system found in microsomes of many cells (liver, kidney, lung, intestine) performs many different functionalization reactions
  • 8. Phase I • Converts the parent drug to a more polar metabolite by introducing or unmasking a functional group (-OH, -NH2, -SH). • Usually results in loss of pharmacological activity • Sometimes may be equally or more active than parent (Prodrug)
  • 9. Prodrug • Pharmacologically inactive • Converted rapidly to active metabolite (usually hydrolysis of ester or amide bond) • Maximizes the amount of active species that reaches site of action • Eg Enalpril to enalprilat • Levodopa to dopamine
  • 10. Endoplasmic Reticulum (microsomal) and Cytosol With respect to drug metabolizing reactions, two sub cellular organelles are quantitatively the most important: the endoplasmic reticulum and the cytosol. The Phase I oxidative enzymes are almost exclusively localized in the endoplasmic reticulum (Microsomal). Egs P450, Glucuronyl transferase Phase II enzymes are located predominantly in the cytosol. Egs esterases, amidases, conjugases
  • 11.
  • 12. Cytochrome P450 Monooxygenase System • Superfamily of heme containing proteins Involved in metabolism of diverse endogenous and exogenous compounds – Drugs – Environmental chemicals – Other xenobiotics
  • 13. Cytochrome P450 Nomenclature and Multiple Forms • About 1000 are currently known cytochrome P450s, about 50 active in humans • Basis of nomenclature system: P is pigment, 450 absorption at 450 nm
  • 14. • categorized into 17 families (CYPs) – sequences > 40% identical – identified by Arabic number, CYP1, CYP2 • further into subfamilies – identified by a letter, CYP1A, CYP2D
  • 15. These are the types of reactions performed by the Cytochrome P450 system • Aromatic hydroxylation Phenobarbital, amphetamine • N-Dealkylation Diazepam • Aliphatic hydroxylation Ibuprofen, cyclosporine • Epoxidation Benzo [a] pyrene • O- Dealkylation Codeine • S- Dealkylation 6-Methylthiopurine • Oxidative Deamination Diazepam, amphetamine • N-Oxidation Chlorpheniramine • S-Oxidation Chlorpromazine, cimetidine • Phosphothionate oxidation Parathion • Dehalogenation Halothane • Alcohol oxidation Ethanol
  • 16. Phase I Metabolism Summary • The final product usually contains a chemical reactive functional group OH, NH2, SH, COOH. • This functional group can be acted upon by the phase II or conjugative enzymes. • Main function of Phase I metabolism is to prepare the compound for phase II metabolism, not excretion.
  • 17. Phase II (conjugation reactions) • Subsequent reaction in which a covalent linkage is formed between a functional group on the parent compound or Phase I metabolite and an endogenous substrate such as glucuronic acid, sulfate, acetate, or an amino acid • Highly polar – rapidly excreted in urine and feces • Usually inactive – (exception is morphine 6- glucuronide) • Eg sulphonamides, adrenaline, chloramphenicol
  • 18. Phase II Metabolism • Phase II is usually the true detoxification of drugs • Occurs mostly in cytosol • Gives products that are generally water soluble and easily excreted • Includes sugar conjugation, sulfation, methylation, acetylation, amino acid conjugation, glutathione conjugation
  • 19. Glucuronidation • Most widespread, important of the conjugation reactions. • compounds with hydroxyl or carboxylic acid group are conjugated with glucuronic acid. • Other sugars, glucose, xylose or ribose may be conjugated • Egs oral contaceptives
  • 20. Sulfation • Major conjugation pathway for phenols, also alcohols and amines • Compounds that can be glucuronidated can also be sulfated • Can be competition between the two pathways • Sulfate conjugation - low substrate concentration • Glucuronide conjugation - high substrate concentration • Compds are sulfated by sulfokinases eg Chloramphenicol.
  • 21. Glutathione Conjugation • Glutathione is a protective compound within the body for removal of potentially toxic electrophilic compounds • Many drugs are, or are metabolized in phase I to, strong electrophiles eg quinone residues • React with glutathione to form non- toxic conjugates • Glutathione conjugates may be excreted directly in urine or bile.
  • 22.
  • 23. Factors affecting Drug Metabolism • Environmental Determinants Induction Inhibition • Disease Factors • Age and Sex • Genetic Variation
  • 24. Environmental Determinants • Activity of most drug metabolizing enzymes can be modulated by exposure to certain exogenous compounds Drugs Dietary micronutrient (food additives, nutritional or preservative) Environmental factors (pesticides, industrial chemicals) • Can be in the form of induction or inhibition • Contributes to interindividual variability in the metabolism of many drugs
  • 25. Induction of Drug Metabolism Enzyme induction is the process: Certain substrates (e.g., drugs, environmental pollutants) causes increased activity/ synthesis of certain enzymes resulting in increased metabolism of administered drug.
  • 26. Induction of Drug Metabolism • Many currently used drugs are well known to induce their own metabolism or the metabolism of other drugs. Some examples are the anticonvulsant medications phenobarbital and carbamazepine. • Cigarette smoking can cause increased elimination of theophylline and other compounds.
  • 27. Consequences of Induction 1. Increased rate of metabolism 2. Decrease in drug plasma concentration 3. Enhanced oral first pass metabolism 4. Reduced bioavailability 5. If metabolite is active or reactive, increased drug effects or toxicity
  • 28. Therapeutic Implications of Induction • Drugs with active metabolites can display increased drug effect and/or toxicity due to enzyme induction • Dosing rates may need to be increased to maintain effective plasma concentrations
  • 29. Inhibition of Drug Metabolism • Drug metabolism can be subjected to inhibition. • Drugs and other substances can inhibit the metabolism of other drugs.
  • 30. Some types of inhibition • Competition between substrates for enzyme active site • Concentration of substrates Affinity for binding site (drug with high affinity for an enzyme will slow the metabolism of any low affinity drug) • Irreversible inactivation of enzyme: Eg Complex with heme iron of CYP450 (cimetidine, ketoconazole), Destruction of heme group (secobarbital)
  • 31. Consequences of Inhibition • Increase in the plasma concentration of parent drug • Reduction in metabolite concentration • Exaggerated and prolonged pharmacological effects • Increased liklihood of drug-induced toxicity
  • 32. Therapeutic Implications of Inhibition • May occur rapidly with no warning • Particularly effects drug prescribing for patients on multidrug regimens • Knowledge of the CYP450 metabolic pathway provides basis for predicting and understanding inhibition Esp drug drug interaction
  • 33. Examples of enzyme inducers and inhibitors in metabolism Affected Drugs Inducers Inhibitors Tricyclicantidepressants Propranolol F-Warfarin Theophylline Phenobarbital Phenytoin Rifampin Smoking Char-broiled meats Cimetidine Erythromycin Ciprofloxacin sulfonamides
  • 34. Disease Factors Liver Disease – Cirrhosis, Alcoholic liver disease, jaundice, carcinoma • Major location of drug metabolizing enzymes • Dysfunction can lead to impaired drug metabolism-decreased enzyme activity • First pass metabolism affected • Results in exaggerated pharmacological responses and adverse effects Cardiac failure causes decreased blood flow to the liver Hormonal diseases, infections and inflammation can change drug metabolizing capacity
  • 35. Age • Newborns and infants – metabolize drugs relatively efficiently but at a rate generally slower than adults • Full maturity appears in second decade of life • Slow decline in function associated with aging
  • 36. • Sex: Responsiveness to certain drugs is different for men and women • Pregnancy – induction of certain drug metabolizing enzymes occurs in second and third trimester • Hormonal changes during development have a profound effect on drug metabolism • Genetic predisposition: Lactose intolerance- deficiency of lactase- results in abdominal bloating and cramps, flatulence, diarrhea, nausea
  • 37. Excretion • Urine: salicylates, probenicid • Faeces: unabsorbed fraction, from bile eg steroids and organic bases • Egs erythromycin, rifamipin, tetracyclin, phenolphthalein. • Exhaled air: gases and voletile liquids egs alcohol, paraldehyde, general anesthetics. • Saliva and sweat: Lithium, Pot. Iodide, thiocynates, rifampin and heavy metals • Milk: drug enters milk by passive diffusion. Milk pH is 7 thus basic drug get more into it. Drug should be given cautiously to the lactating mother.
  • 38. • Glomerular filteration: depending on their molecular size. • Tubular absorption: lipid solubility and ionization at urinary pH • Thus pH of urine affects the excretion of drug • Poisoning: barbiturate (acidic) and salicylate, urine is alkalinized. • Acidified incase of morphine and amphetamine poisoning.